Changeflow GovPing Pharma & Drug Safety DEA Houston Warns Counterfeit M30 Pills Contain...
Routine Notice Added Final

DEA Houston Warns Counterfeit M30 Pills Contain Fentanyl

Favicon for www.dea.gov DEA Public Safety Alerts
Published
Detected
Email

Summary

DEA Houston Division issued a public safety alert warning that counterfeit M30 pills (resembling oxycodone) seized during law enforcement operations have tested positive for fentanyl. The agency is urging the public not to use these pills as they pose a deadly risk and are part of the ongoing fentanyl crisis affecting communities.

What changed

DEA Houston Division issued a public safety alert warning that counterfeit M30 pills, which resemble legitimate oxycodone 30mg tablets, have been found to contain fentanyl after laboratory testing. These counterfeit pills are produced by illegal manufacturers and distributed through illicit channels, posing a severe risk of fatal overdose.\n\nHealthcare providers, first responders, and community organizations should share this warning with patients and communities. While this is an informational alert rather than a regulatory action, it highlights the ongoing public health crisis caused by counterfeit pharmaceuticals containing fentanyl.

What to do next

  1. Avoid all pills obtained outside legitimate pharmacies
  2. Report suspected counterfeit drugs to DEA or local law enforcement
  3. Share DEA fentanyl awareness resources with community

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Post

DEAHouston @DEAHOUSTONDiv Don’t gamble with your life. These seized M30 pills may look real-but testing shows they contain fentanyl. Counterfeit pills are deadly. Join the fight: DEA.gov/fentanylfree @DEAHQ @TheJusticeDept ALT
1:33 pm · 8 Apr 2026
256 Views 4


New to X?

Sign up now to get your own personalized timeline! Sign up with Google Sign up with Apple Create account By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.


What’s happening

Trending in United Kingdom Ben Delo Trending in United Kingdom Reform Trending in United Kingdom IPTV Trending in United Kingdom Miriam Show more

Get daily alerts for DEA Public Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DEA.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
DEA
Published
April 8th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Consumers Healthcare providers Law enforcement
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Public safety warning Drug seizure notification
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Compliance
Topics
Pharmaceuticals Consumer Protection

Get alerts for this source

We'll email you when DEA Public Safety Alerts publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.